» Articles » PMID: 15561050

A Closed Perfusion System with Heparin Coating and Centrifugal Pump Improves Cardiopulmonary Bypass Biocompatibility in Elderly Patients

Overview
Journal Ann Thorac Surg
Publisher Elsevier
Date 2004 Nov 25
PMID 15561050
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Cardiopulmonary bypass induces a systemic inflammatory and hemostatic activation, which may contribute to postoperative complications. Our aim was to compare the inflammatory response, coagulation, and fibrinolytic activation between two different perfusion systems: one theoretically more biocompatible with a closed-circuit, complete heparin coating, and a centrifugal pump, and one conventional system with uncoated circuit, roller pump, and a hard-shell venous reservoir.

Methods: Forty-one elderly patients (mean age, 73 +/- 1 years, 66% men) undergoing coronary artery bypass grafting or aortic valve replacement were included in a prospective, randomized study. Plasma concentrations of complement factors (C3a, C4d, Bb, and sC5b-9), proinflammatory cytokines (tumor necrosis factor-alpha, interleukin-6, and interleukin-8), granulocyte degradation products (polymorphonuclear elastase), and markers of coagulation (thrombin-antithrombin) and fibrinolysis (D-dimer, tissue plasminogen activator antigen and tissue plasminogen activator-plasminogen activator inhibitor-1 complex) were measured preoperatively, at bypass during rewarming (35 degrees C), 60 minutes after bypass, and on day 1 after surgery.

Results: The mean concentrations of C3a (-39%; p = 0.008), Bb (-38%; p < 0.001), sC5b-9 (-70%; p < 0.001), interleukin-8 (-60%; p = 0.009), polymorphonuclear-elastase (-55%; p < 0.003), and tissue plasminogen activator antigen (-51%; p = 0.012) were all significantly lower in the biocompatible group during rewarming. Sixty minutes after bypass, the mean concentrations of sC5b-9 (-39%; p = 0.006) and polymorphonuclear-elastase (-55%; p < 0.001) were lower in the biocompatible group.

Conclusions: The results suggest that a closed perfusion system with a heparin-coated circuit and a centrifugal pump may improve cardiopulmonary bypass biocompatibility in elderly cardiac surgery patients in comparison with a conventional system.

Citing Articles

2024 EACTS/EACTAIC/EBCP Guidelines on cardiopulmonary bypass in adult cardiac surgery.

Wahba A, Kunst G, De Somer F, Kildahl H, Milne B, Kjellberg G Eur J Cardiothorac Surg. 2025; 67(2).

PMID: 39949326 PMC: 11826095. DOI: 10.1093/ejcts/ezae354.


2024 EACTS/EACTAIC/EBCP Guidelines on cardiopulmonary bypass in adult cardiac surgery.

Wahba A, Kunst G, De Somer F, Kildahl H, Milne B, Kjellberg G Interdiscip Cardiovasc Thorac Surg. 2025; 40(2).

PMID: 39949317 PMC: 11826094. DOI: 10.1093/icvts/ivaf002.


Neutrophils: a key component in ECMO-related acute organ injury.

Zhang M, Li S, Ying J, Qu Y Front Immunol. 2024; 15:1432018.

PMID: 39346902 PMC: 11427252. DOI: 10.3389/fimmu.2024.1432018.


Strategies to attenuate maladaptive inflammatory response associated with cardiopulmonary bypass.

Banerjee D, Feng J, Sellke F Front Surg. 2024; 11:1224068.

PMID: 39022594 PMC: 11251955. DOI: 10.3389/fsurg.2024.1224068.


A modified low-priming cardiopulmonary bypass system in patients undergoing cardiac surgery with medium risk of transfusion: A randomized controlled trial.

Gao S, Liu G, Wang J, Zhang Q, Wang J, Teng Y Heliyon. 2024; 10(11):e31388.

PMID: 38832269 PMC: 11145224. DOI: 10.1016/j.heliyon.2024.e31388.